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The  preceding  article  contains  evidence  for  the  existence  on  all  B 
lymphocytes,  but  not  on  T  lymphocytes,  of  a  membrane-associated  receptor 
for  antibody  (1).  Antibody-binding  lymphocytes  were  detected  by a  sensitive 
radioautographic  technique  using  125I-labeled  antigens.  The  present  paper  is 
devoted to a  study of the type of antibody  capable of attachment  to the B  cell 
and  the distribution  of this  receptor  on the cell surface.  Data  are presented  to 
show that the receptor, although a marker for mature B  cells (antibody-forming 
cell precursors),  is absent  from hematopoietic precursor  cells and is lost during 
differentiation  to antibody-forming  cells. 
Materials and Methods 
Animals.--Mice  of  the highly inbred  CBA strain  were used  as  a  source of cells  in  the 
majority of experiments (i). Tumors (vide infra) were serially transplanted in syngeneic mice. 
Their strain  of origin, induction,  and  maintenance will be described  elsewhere. 1 Five lines 
(plasma  cell  tumors  MOPC-460,  XCI  and  HPC-6,  lymphoma  SIAT.4,  and  mastocytoma 
P815)  were obtained from Dr. A. W. Harris as continuous cultures in vitro. 
Thoracic Duct Cannulation.--Cannulation was  carried  out by  the method  of Miller and 
Mitchell (2). 
Thymectomy.--The procedure for preparing adult thymectomized irradiated bone marrow 
protected mice (TxBM) 2 was described in the previous paper (1). 
Irradiation.--This  was carried out as in reference 1. 
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2 Abbreviations used in this paper: BSA, bovine serum albumin; CoF, purified low molecular 
weight  anticomplementory  factor;  FCS,  fetal  calf  serum;  F'FG,  fowl  immunoglobulin  G; 
HGG, human  gamma globulin; SRBC, sheep red blood cells; TDL,  thoracic duct lympho- 
cytes; TxBM, adult thymectomized, irradiated, and marrow protected. 
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Preparation i( Call Suspensions.  Single  cell  suspensions of  spleen,  bone  marrow,  and 
thoracic duct lymphocytes (TDL) were obtained as outlined in the previous paper (1). Unless 
otherwise stated TDL from normal mice were used in all assays. 
Anligens.--Fowl  immunoglobulin  IgG  (FTG)  was  obtained  from  chicken  serum  as  de- 
scribed previously (3). Before iodination it was absorbed extensively against mouse lympho- 
cytes to remove nonspecific anti-nmuse activity. 
Iodination.  FTG was iodinated with  125I (Radiochemical Centre, Amersham, England, 
catalogue No.  IMS 3)  according to  the method of Byrt and Ada  (4).  A  specific activity of 
approximately 50 #Ci/#g FTG was used in all experiments with the exception of the electron 
microscope studies where a  higher level of radioactivity viz.  150 #Ci/#g was required. 5% 
bovine serum  albumin  (BSA)  (Cohn fraction V, Armour  and  Company Ltd.,  Eastbonrne, 
England) provided a source of carrier protein in the procedure. 
Antisera.  Antisera to FTG were obtained from hyperimmune CBA mice as described in 
the previous paper  (1)  and heat inactivated before use. Their antibody activity and that of 
any fragments prepared from them was titrated by a hemagglutination technique using sheep 
red blood cells (SRBC) coated with fowl anti-SRBC IgG (3). 
Assay for A ntibody-Binding Cdls.--A detailed description of the assay was presented in the 
previous paper (1).  Briefly, single cell suspensions were incubated for ~  hr at 37°C in whole 
anti-F3,G antiserum or in various antibody fractions obtained from it at a  concentration of 
50  X  10 ~ cells/ml. The cells were then centrifuged once, the supernatant removed, and the 
cell  pellet  resuspended immediately in  a  solution  of FTG-125I.  After a  further  incubation 
period of 1/~ hr at 4°C, the cells were washed free of excess radioactive matmial by centrifuga- 
tion  through  gradients  of  fetal  calf  serum  (FCS)  (Commonwealth  Serum  Laboratories, 
Melbourne, Australia).  Smears for radioautography were made in 100% FCS and processed 
as described previously (1). In general 500-1000 cells were counted per slide. 
BSA  Gradients.  In experiments designed to examine whether complement was required 
for  binding of antibody to B  cells, it was essential to avoid  exposing the lymphocytes to a 
source of complement at any stage of the assay.  Gradients for removal of excess F3,G-125I 
were therefore made with B SA not FCS. A stock solution of BSA, pH 5.1, was prepared accord- 
ing to the method of Shortman et al. 3 Before use it was diluted with unbuffered salt solution 
to a  final concentration of 20% w/w  (density 1.060  g/mm 3 at 4°C). Cells to be centrifuged 
through BSA were suspended in Dulbecco's phosphate-buffered saline (5) of mouse isotonicity. 
The osmolarity of this solution was 269 mOsM which is equivalent to 0.168 M NaC1. 4 
Electron Microscope Radioautography.  Ceils for study were labeled with anti-FTG  and 
t:'1,G-125I  of high specific activity (viz.  150 #Ci/#g FTG)  as described above. After removal 
of excess radioactive antigen, they were divided into aliquots one of which was processed for 
standard light microscopy. The other was resuspended in 50~ FCS and centrifuged in small 
cellulose nitrate Spinco tubes (3/16  X  15/8 inch)  (Spinco Division of Beckman Instruments, 
Inc., Palo Alto, Calif.). The loose pellet was fixed in the tube by layering over it 2.59~  glu- 
taraldehyde  in  0.1  M cacodylate  buffer.  5  min later  the glutaraldehyde was  removed  and 
replaced with fresh fixative for a  further 2 hr. The bottom of the tube containing the fixed 
cells was then cut off and placed in a  large volume of buffer (0.1  ~t cacodylate)  overnight. 
Finally the pellet was postfixed in 2% osmium tetroxide for 2 hr and dehydrated in a graded 
series of acetone. Absolute acetone dissolved the cap of cellulose nitrate protecting the pellet. 
3 Shortman, K., N. Williams, and P. Adams. The separation of different cell classes from 
lymphoid  organs.  V.  Simple procedures for  the removal of cell debris, damaged ceils, and 
erythroid cells from lymphoid cell suspensions. Submitted for publication. 
4 Williams, N., N. Kraft, and K. Shortman. The separation of different cell classes from 
lymphoid organs. VI. The effect of osmolarity of gradient media on the density distributioIl 
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This method allowed very small quantities of cells to be processed since losses due to mechan- 
ical handling of the pellet were avoided. After embedding in Araldite (Ciba Pharmaceutical 
Company, Summit, N. J.) thin sections (600-800 A) were cut with glass knives on aR LKB 
Ultrotome III ultramicrotome (LKB Instruments Inc., Rockville, Md.). The sections were 
picked up with a fine glass probe and placed on a drop of glass distilled water on a collodion- 
coated slide. After drying, the slide was coated with a thin layer of carbon (approximately 50 A 
thick), dipped in Kodak NTE emulsion, and exposed for 10-14 days. The exposed slides were 
developed in Dektol (Kodak) and after fixation, the sections were stripped off and mounted on 
unsupported 100-mesh copper grids. The cells were examined unstained in a Philips EM 300 
electron microscope (Philips Electronic Instruments, Mount Vernon, N. V.) at 60 kv. In 
addition to radioautographs, conventional thin sections stained with uranyl acetate and lead 
citrate were examined. 
Fractionation of Antisera.--A pool of hyperimmune CBA anti-F3'G serum was separated 
into IgM- and IgG-containing fractions by gel filtration through Sephadex G-200 (Pharmacia 
Fine Chemicals Inc., Uppsala, Sweden). Electrophoretic separation of a slow migrating IgG 
fraction was made in starch Geon with a pH 8.5 Veronal buffer. Separation into IgG2- and 
IgGl-rich fractions was made by electrophoresis in 1% Ionagar pH 8.2 Veronal buffer on glass 
plates as previously described (6). Quantitative estimation of IgG1 and IgG2 content of these 
fractions was performed by the inhibition of precipitation technique using 125I-labeled mye- 
loma proteins and monospecific heavy chain antisera (6). Preparation of the Fab fragment by 
papain digestion was performed according to the method of Porter (7). 
Im munoglobulin Preparations for Inhibition Studies.--A series of purified myeloma proteins 
were isolated by standard methods (8) from the sera of mice bearing plasma cell tumors. The 
immunoglobulin class of the proteins used is given in Tables II and III. The IgG fractions of 
several class specific rabbit anti-mouse immunoglobulin sera were isolated by electrophoresis 
in starch Geon (pH 8.5 Veronal buffer). Pepsin digestion (1:50 ratio pepsin to protein) was 
performed as previously described (9) followed by separation of the F(ab)'2 fragment on Sepha- 
dex G-150 gel filtration. 
RESULTS 
Direct Binding of Fraaionated Antisera to B Lymphocyles.--To determine 
whether the property of binding of an antibody to the B cell surface was shared 
by all immunoglobulin classes, a standard pool of mouse anti-F3,G antiserum 
was fractionated by electrophoresis and gel filtration. The original antiserum 
and fractions obtained from it were incubated with normal TDL (12 20% of 
which are usually B cells [1]) followed by FyG-12% 13 % of this particular TDL 
preparation bound the unfracfionated antiserum (Table I). The binding 
capacity of the various fractions was then compared by using amounts contain- 
ing similar antibody activity. Significant labeling occurred with the excluded 
IgM fraction from Sephadex G-200 gel filtration, although the quantity of 
antigen bound in the complex was less, as shown by mean grain counts. 
Electrophoretic separation of the antiserum in agar gel, resulted in a relatively 
pure IgG2 fraction (containing IgG2~ and IgG2b) and a faster migrating fraction 
which had approximately equal amounts of IgG1 and IgG2. Although both 
fractions gave significant binding, the percentage of cells with complexes, and 
the amount of complex as determined by grain counts, was greater with the 
fraction containing IgG1 antibody. 
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significant  number  of TDL,  whereas  a  similar  concentration  of the  Fab  frag- 
ment of this fraction gave no binding at all. 
Inhibition of Antibody Binding to B  lymphocytes  by Purified Mouse Immuno- 
globulins.--Since  it  is  relatively  difficult  to  obtain  completely purified  mouse 
IgG  subclasses  by  electrophoresis,  a  further  examination  of  possible  hetero- 
geneity in B  cell  binding  of subclasses  was made by comparing the  ability  of 
purified mouse myeloma proteins to inhibit the binding of a standard antibody 
preparation.  In these experiments, TDL were treated for 3 hr at 4°C with vari- 
ous amounts of purified immunoglobulins.  At the end of this period  anti-F3,G 
antibody (titer 1:512) was added to a final concentration of 1 in 500 and incuba- 
tion continued for a further }3 hr at 37°C. The cells were then centrifuged and 
resuspended  in  F3,G-125I in  the  usual  way for  radioautography.  Control  cells 
were treated  in the same manner except immunoglobulin was excluded. In the 
first set of experiments,  inhibition  with immunoglobulins from various sources 
was  examined.  As  shown  in Table  II labeling  was  completely blocked by all 
IgG1 samples used and partially blocked by IgG2b and IgM myeloma proteins. 
TABLE I 
Direct Binding of lmmunoglobulin Fractions to B Lymphocytes 
Immunoglobulin fractions from  Per cent TDL labeled  Mean  grain counts  per 
anti  F~,G  antiserum*  with FvG-mI  labeled cell; 
% 
Whole anti-F3'G antiserum  13  >>100 
IgM  7.5  27 
IgG2  5.5  38 
IgG1 q- IgG2§  10  90 
IgG§ [I  14  > 100 
Fab fragmentl]  < 1  < 1 
* Samples were diluted  so that cells were exposed to comparable  amounts  of antibody 
activity.  In the case of the Fab fragment, a comparable protein concentration  was used. 
:~ Obtained from one experiment. Similar results were obtained in two other experiments. 
§ After  reaction  with  F3,G-125I, cells were centrifuged  through  BSA  (complement  free) 
gradients. 
1] Containing all three IgG classes. 
In contrast, IgG2a, IgA, and light chain myeloma proteins at the same concen- 
tration  (2  mg/ml)  were without effect. A  single  immunoglobulin of each class 
was then  selected and the degree of inhibition  determined  for various concen- 
trations  (Table  III). At a  concentration of 0.5  mg/ml  blocking of labeling  oc- 
cured only with IgG1 myeloma protein. These results thus confirmed that IgG1 
.globulin was the most effective competitor with antibodies for the Fc  receptor 
on B  cells. 
Complement Independence  of A ntibody Binding to B Lymphocytes.--The failure 
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TABLE  II 
Inhibition  of Binding  of Antibody  to B  Lymphocytes  with Purified  Mouse  Immunoglobulin 
Effect of Immunoglobulins from Different Tumors 
Source of imrnunoglobulin  Type of immunoglobulin (2 mg/ml)  Per cent TDL labeled with  anti-F3,G" F~,G-tZ~I 
% 
-  -  15 
-  -  16 
-  -  13 
HPC-77  IgG1  <  1 
HPC-81  <  1 
HPC-39  <  1 
HPC-3  IgG2a  13 
HPC-56  15 
GPC-7  15 
HPC-84  IgG2b  3 
HPC-71  3 
MPC-86  6 
HPC-1  IgA  14 
HPC-38  17 
HPC-76  IgM  5* 
HPC-14  Light chains  14 
HPC-4  16 
* IgM protein only available from one tumor. This figure represents the mean of results 
from two experiments. 
TABLE  III 
Inhibition  o[ Binding  oJ Antibody  to B  Lymphocytes with Purified  Mouse Immunoglobulins. 
Effect of Varying Concentrations of a Single Immunoglobulin 
Source of immunoglobulin  Type of immunoglobulin 
Per cent TDL labeled with anti-F3,G" FyG-12~I 
after incubation with various concentrations of 
immunoglobulin (mg/ml) 
0.2  0.5  f  2 
% 
-  -  17 
HPC-39  IgG1  3.5  < 1  < 1  <  1 
HPC-3  IgG2~  15  14  15  18 
HPC-84  IgG2b  16  12  8  4 
HPC-1  IgA  14  20  16  14 
HPC-76  IgM  -  14  -  6 
HPC-14  Light chain  15  15  19  17 632  ANTIBODY  RECEPTOR  ON  B  LYMPHOCYTES.  II 
whether complement was required for binding to the receptor.  Several lines of 
evidence suggesting that the process is complement independent have already 
been presented. For example, significant binding occurred with heat-inactivated 
antiserum  at  dilutions up  to  1:500,  and  with  the  electrophoretically  slow 
migrating fraction of IgG which was relatively complement free. Furthermore, 
IgG1 myeloma protein was the most effective inhibitor of labeling with anti- 
F3'G. F3'G-~2aI, while,  as  shown in the  previous paper  (1),  antisera raised in 
chickens, the IgG fraction of which does not fix mammalian complement (10), 
adhered to B cells as effectively as isologous antiserum. None of these findings, 
however, formally excluded possible involvement of C'3. To examine this ques- 
tion  a  potent  inhibitor of  C'3  (11),  the  purified low  molecular weight  anti- 
complementary factor (CoF) from the cobra Xaja naja was used. 
TABLE IV 
Effect of Purified Cobra Venom  Factor (CoF) on Binding of A nlibody to B Lymphocytes 
Pretreatment of anti-F~,G antiserum* 
Per cent labeling of TDL with F,yG-lesI 
1:~  2+  + 
?~  % 
NIL  15  12 
Nonactivated CoF  16§  10§ 
Activated CoF  13§  9§ 
* Dilution 1:500. 
:~ Results from two separate experiments. 
§ No difference in grain counts per cell was observed between cells treated with nonacti- 
vated and activated  CoF. 
CoF was obtained in lyophilized form s and dissolved in phosphate-buffered saline, pH 7.3, 
at a concentration of 500 units/ml. Activation was carried out by treatment with fresh rabbit 
serum at 37°C for 20 min. 5 20 units of activated or nonactivated CoF were then added to 0.2 
ml of inactivated anti-FTG  antiserum (titer 1 : 256, dilution 1:500) and incubated for a further 
30 min at 37°C. At the end of this period the two samples of anti-FTG antibody were added 
to separate aliquots of 107 normal TDL. Incubation was continued for 30 min at the same 
temperature  after  which the cells were centrifuged and resuspended with FTG-125I in the 
usual way. 
As shown in Table IV, no significant reduction in labeling with F'yG-12aI was 
observed even when the cells were exposed to antiserum treated with up to 20 
units of activated CoF. This suggests that soluble imnmne complexes bind to B 
cells independently of complement components. 
Relationship between Membrane-A ssociated Immunoglobulin and Receptors jor 
Antibody  on  B  Lymphocytes.--B  lymphocytes  are  known  to  possess  a 
high density of immunoglobulin  molecules on their surface. The question there- 
fore arose whether the receptor for the Fc portion of antibody was associated 
5 Obtained from Dr. C. G. Cochrane by Dr. Marc Feldmann. A.  BASTEN,  N.  L.  WARNER,  AND  T.  MANDEL  633 
with the  immunoglobulin. To examine this,  TDL were incubated  with either 
normal rabbit IgG F(ab)'2 or with the F(ab)'2 fractions from rabbit anti-mouse 
immunoglobulin sera for 3 hr at 4°C. Pepsin-digested fragments were used in- 
stead  of  intact  anti-globulins  to  avoid both  nonspecific  inhibition  by rabbit 
anti-mouse-mouse immunoglobulin complexes and nonspecific labeling of rabbit 
anti-mouse-mouse  anti-F3,G  complexes with  '25I antigen.  At  the  end  of  this 
period anti-F3,G antiserum was added to the suspension to a final concentration 
of 1:500 and incubation continued for a further 1/~ hr interval, this time at 37°C. 
The cells were then centrifuged and reacted with F3,G-l~sI  in the usual manner. 
Thus  the  steps  in  this  procedure  were identical  to  those  in  the  experiments 
where sucessful inhibition of antibody binding with myeloma proteins was ob- 
tained (vide supra). It is clear, however, from the data in Table V that none of 
the F(ab)'2 fractions prevented access of antibody-antigen comlzlexes to B cells 
TABLE  V 
Failure of Rabbit Anti-Mouse  Immunoglobulin F  (ab)'2 Fragments to Inhibit B~ nding of Antibody 
to B Lymphocytes 
F(ab)'~ fragments*  Per cent labelir g of TDL with 
anti-F~,(  -  FTG-~2~I 
% 
Normal rabbit IgG F(ab)'2  16 
anti-~ F(ab)'2  14 
anti-/~ F(ab)'2  16 
anti- T F(ab)'2  19 
* Used at a concentration of 1.8-2.4 mg/ml. 
,even when concentrations of protein similar to those required for effective block- 
ing with immunoglobulins (Tables II and III) were used. 
Electron Microscope  Radioautography of B Lymphocytes Coated with anti-F'l,G. 
F3,G-'25I.--The use of a  radioautographic technique for detectim of receptors 
for antibody on B  cells permitted visualization of their surface  Jistribution by 
.electron microscopy. TDL from TxBM donors (containing approximately 70% 
labeled cells by light microscopy) were selected for ultrastructural  study. Ex- 
amination of stained specimens revealed that 65-70 % of cells wet e lymphocytes. 
Of the remainder the majority had features of plasma cells or plasma blasts al- 
though  a  few granulocytes  (4-5%)  and  occasional  monocyte-like cells  (1%) 
were also seen. In the radioautographs most of the lymphocytes were labeled 
regardless of size. They displayed a  characteristic distribution  ,)f grains which 
took the form of discrete patches on their surface often scattered at irregular 
intervals (Fig. 1). Between patches the cell surface was free of gr~ ins. Occasional 
grains seen over the cell substance could not be distinguished frcm background. 
In contrast cells clearly identifiable  as plasma blasts or plasma cells failed to 
bind labeled material (Fig. 2). A few transitional types with mini hal amounts of 634  ANTIBODY RECEPTOR ON  B  LYMPHOCYTES. II 
rough  endoplasmic reticulum did  so.  Cell  debris  (Fig.  3)  and  the  occasional 
monocyte-like cell (Fig. 4) were frequently labeled. In the former case, however, 
the silver was present as single grains which were obviously associated with the 
debris, while in the  latter the  grains were  seen overlying lysosome-like cyto- 
plasmic vacuoles, not surface structures. 
FIG. 1.  Electron microscope radioautograph  of a small lymphocyte from thoracic duct 
lymph of TxBM mice which had been exposed in vitro to anti-Fb'G-Fb'G-125I. The cell shows 
dense patches of label at the cell surface but the major part of the surface is free of grains. 
Scattered single grains are present over the nucleus but these are consistent with the back- 
ground label found in the section. Exposure 14 days, unstained section. X 21,000. 
Relationship  between  Differentiation  in  B  Cells  and  their  Receptor  for 
Antibody.--Modifications  in surface alloantigens during lymphocyte differentia- 
tion have now been well documented (12). It was therefore of interest to deter- 
mine  whether  changes  occurred  in  the  antibody-binding receptor  during  B 
differentiation. The possible presence of the receptor on stern cells was examined 
by use of a column technique designed to deplete cell populations of B lympho- 
cytes carrying the receptor (13). 
Polymethylmetaacrylic  beads (Degalan V26, Degussa Wolfgang AG, Hanau am  Main, A.  BASTEN~ N.  L.  WARNER,  AND  T.  MANDEL  635 
Germany) were coated with an antigen such as human gamma globulin  (HGG)  (Common- 
wealth Serum Laboratories) and poured into glass columns. Suspensions of spleen and bone 
marrow  cells were incubated with rabbit anti-HGG serum  at  a  concentration of 5  X  107 
cells/ml for ~  hr at 37°C.  They were then centrifuged once, resuspended in  tissue culture 
Medium 199 containing 10% normal mouse serum, and poured into the columns (150 >(  106 
cells to each column). After a further 1 hr incubation at 4°C, during which cells such as mature 
B  lymphocytes  with  antibody on  their surface  adhered  to  the  antigen-coated  beads,  the 
FIG.  2.  Electron microscope radioautograph of an  immature plasma  cell from  thoraci 
duct lymph of TxBM mice which had been exposed in vitro to anti-F'),G.F3,G-125I. Dens 
patches of label are strikingly absent. Scattered single grains represent background. A neigh 
boring lymphocyte (partially visible) is heavily labeled. Exposure 14 days, unstained section 
X  18,200. 
effluent was collected and divided into two pools. The first pool was reacted with anti-F3'G. 
F3~G-12sI to  check  that B  cell depletion had occurred.  The  second pool was  counted  and 
tested for  its stem  cell  content by the colony-forming assay  of Till  and  McCulloch  (14). 
Graded numbers of column-treated cells and controls were injected intravenously into heavily 
irradiated  (800 rads)  syngeneic hosts.  7 days later the spleens were removed and placed in 
Bouin's fixative. Macroscopically visible colonies were counted and related to the number of 
injected cells. 
It  was  predicted  that  column-treated  cell  suspensions  would  be  markedly 
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FIG.  3.  Electron microscope radioautograph  of cell debris from  the same source as the 
~:ells seen in Figs. 1 and 2 showing an aggregation of grains clearly associated with the debris. 
Although numerous grains are present they do not form discrete patches like those found on 
abeted lymphocytes. Exposure 14 days, unstained section. X  18,000. 
FIG.  4.  Electron microscope radioautograph  of a  portion  of a  phagocytic thoracic duct 
cell from TxBM mice showing intracellular localization of labeled immune complex. A  large 
multimolecular patch is present overlying a  clear vacuole deep in the cytoplasm. Other lyso- 
some-like vesicles are  also present but  are unlabeled.  Exposure  14  days,  unstained  section. 
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cells carried the receptor for antibody. This was not found and in fact a three- 
to fourfold enrichment was observed instead (Table VI). In other words, most, 
if not all, precursor cells lack this membrane-associated receptor. 
The electron microscopy findings already reported suggested that the receptor 
for antibody was absent from antibody-forming cells  as well  as from the pre- 
cursors of B  cells.  Support  for this  was obtained  by examining  the  antibody- 
binding properties  of pure populations  of malignant plasma cells.  Tumor cells 
were obtained from either in vitro continuous cell culture lines or from in vivo 
transplanted  tumors.  Eight plasma cell  tuniors were studied,  and  all  but  one 
proved completely negative. The positive line, HPC-6, is a variant derived from 
an NZB IgA-secreting tumor and now only secretes light chains. It should, how- 
TABLE VI 
Failure to Detect the Receptor for Antibody on Precursors of B  Lymphocytes 
Source of cells 
CFU activity* 
CFU/10~  cells  Total  CFU;~ 
Spleen before column treatment 
Spleen after column treatment§ 
Bone marrow before column treatment 
Bone marrow after column treatmentll 
4.5  6750 
12.5  6000 
28  42,000 
120  48,000 
* CFU =  colony forming units. 
:~ Six recipients per group. Data from one experiment. Two others gave similar results. 
§ Yield was 32% of 150 X  106 cells put on column. 
II Yield was 27% of 150 X  106 cells put on column. 
ever,  be  noted  that  of  the  seven  negative  tumors,  two  also  secreted 
only immunoglobulin light chains. One 0-positive lymphoma has been included 
as a negative control and three myeloid-type lines as positive controls, namely 
a  mastocytoma  (receptor  for  immune  complexes  previously  described6),  a 
myelomonocytic leukemia,  and a reticulum cell sarcoma type A  (Table VII). 
DISCUSSION 
Evidence  has  been  presented  for  the  existence  on  B  lymphocytes  of 
a  membrane-associated  receptor  for antibody  (1).  The  receptor was  detected 
radioautographically by treating cells with antibody followed by the correspond- 
ing radioiodinated antigen. Formation of a stable antibody-antigen complex on 
the cell surface by this technique implied that attachment of antibody to recep- 
tor occurred via the C terminal  end of the molecule. The ability of intact IgG 
antibody to bind and the failure of Fab fragments from the same source to do so 
(Table I) supported this notion. The fact that antibody adhered to the receptor 
6 Cline, M. J., and N. L. Warner. Immunoglobulin receptors on a mouse mast cell tumor. 
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by way of its Fc portion made  it important,  particularly from the functional 
point of view, to establish which heavy chain classes or subclasses the receptor 
could recognize. This question was examined in two different ways. In the first, 
various antibody fractions were tested directly for their ability to adhere to B 
lymphocytes. IgM and total IgG globulin both bound to an appreciable number 
of cells as did fractions enriched for IgG1 and IgG2 subclasses. A marked differ- 
TABLE VII 
Failure  to Detect the Receptor for Antibody on Malignant Plasma Cells 
Immunoglobulin Binding of 
Strain of origin  Tumors  Tumor type  synthesized  anti-F~,G" 
and secreted  F~,G-I~sI  * 
(BALB/c  HPC-64  Plasmacytoma  L chain  -- 
X  NZB)F1 
BALB/c  HPC-76  Plasmacytoma  IgM  -- 
BALB/c  MOPC-104E  Plasmacytoma  IgM  -- 
(BALB/c  HPC-32  Variant plasma-  L chain  -- 
X  NZB)F1  cytoma 
(BALB/c  HPC-38  Plasmacytoma  IgA  -- 
X  NZB)F1 
BALB/c  MOPC-460:~  Variant plasma-  NIL  -- 
cytoma 
C3H  XCI~  Variant plasma-  NIL  -- 
cytoma 
BALB/c  SIAT .4{C  0-positive lymphoma  NIL  -- 
NZB  HPC-6:~  Variant plasma-  L chain  q-§ 
cytoma 
(NZB  T  171-3  Reticulum  cell sar  NIL  + 
X  C57BL)F1  coma (type A) 
BALB/c  WEHI-3  Myelomonocytic  NIL  q- 
leukemia 
DBA2  P815{C  Mastocytoma  NIl.  -t- 
* Anti-FTG sera used here bound to 16% normal TDL. 
:~ Lines maintained in continuous  culture in vitro. 
§ Plus sign means  that 90-100%  of viable tumor cells were labeled. 
ence in percentage of binding cells and in grain counts  per cell, however,  was 
observed.  Thus  total  IgG  globulin labeled more  heavily than  did IgM,  and 
IgGl-containing  fractions  more  heavily  than  IgG2  fractions  lacking  IgGi. 
These  findings  suggested that  the  receptor displayed the  highest  avidity for 
IgG1 heavy chains. 
Inhibition of  antibody binding with  purified immunoglobulins provided  an 
alternative way of studying the types of immunoglobulin capable of attachment 
to the receptor (Tables II and III). Pretreatment of B  cells, with excess IgG2,, 
IgA, or light chain myeloma proteins failed to block the subsequent uptake  of 
antibody, whereas IgG1 proteins and to a lesser extent IgG,,h, and IgM proteins A.  BASTEN,  N.  L.  WARNER,  AND  T.  iViANDEL  639 
at the same concentrations did so. When the protein concentration of the solu- 
tion was reduced fourfold (from 2 mg/ml to 0.5 mg/ml), IgG1 myeloma protein 
alone proved capable of inhibition. Taken together, the binding and blocking 
experiments suggest that the receptor on B cells has a marked predilection for 
IgG1 antibody. IgM and IgG2b antibody may bind but with lower avidity and 
probably in insignificant amounts if IgG1 antibody is present in excess.  The B 
cell and the macrophage with its receptor for IgG,~ antibody (15) thus have the 
potential to bind antibody of the major classes and all  the IgG subclasses.  It 
is interesting to speculate what role an array of receptors of this kind may play 
in antigen trapping in lymphoid tissue  or antibody-mediated regulation of the 
immune response (1). 
The need for an intact Fc piece for attachment of antibody to receptor made 
it essential to examine whether complement was required during formation of 
the bond. Data presented here (Table IV) and in the previous paper (1) strongly 
suggest that complement components play no role, at least in the case of soluble 
immune complexes. For example, binding occurred with inactivated antiserum 
at high  dilution with  chicken immunoglobulin which  cannot fix mammalian 
complement (10)  and with  the electrophoretically slow migrating fraction of 
IgG which was  relatively complement free. Particularly important,  however, 
is the evidence (vide supra)  which indicates that receptor recognizes the non- 
complement-fixing IgG1 class. Finally, lack of inhibition of binding by activated 
CoF excluded a possible role for heat stable C13. The formation of antibody- 
antigen complexes on the B cell surface in the absence of complement is appar- 
ently contrary to the previous findings of Bianco et al.  (16). In their system 
particulate complexes in the form of antibody-coated erythrocytes only made 
rosettes around B  cells in the presence of C'3. The discrepancies between our 
system and theirs have already been discussed in the previous paper (1). Failure 
to implicate complement in the binding process, does not, however, exclude the 
possibility that the receptor itself might contain or be composed of a comple- 
ment component. The use of specific antisera should resolve this problem. 
The relationship between the receptor on B  cells  for antibody and surface 
immunoglobulin was examined by a competitive inhibition technique. Lympho- 
cytes were treated with a variety of specific anti-immunoglobulin F(ab)P~ frag- 
ments followed by antibody and radioiodinated antigen (Table V). None of the 
reagents used significantly blocked attachment of antibody to B cells.  In pre- 
liminary experiments with the reverse procedure, preincubation of lymphocytes 
with immune complexes has failed to prevent labeling of B cells with the IgG- 
I25I fraction from a polyvalent anti-immunoglobulin serum3 The receptor for 
antibody and surface immunoglobulin (the receptor for antigen) would there- 
fore appear to be discrete entities on the B cell membrane. Similar findings have 
been reported by Bianco and Nussensweig in their rosette system (17). 
7 Kindly provided by Miss H. Lewis (specific  activity, 50 #Ci/~tg). 640  ANTIBODY  RECEPTOR  ON  B  LYMPHOCYTES.  II 
The use  of a  radioautographic technique for detection of antibody-binding 
lymphocytes enabled us to visualize distribution of the receptor for antibody by 
electron microscopy. Its morphology (Fig. 1) was identical to that described for 
antigen-binding receptors (18). Thus only a small proportion of the cell surface 
appeared to be involved in recognition of antibody, the remainder presumably 
being modified for other functions. Not all  cells  in the  preparation examined 
(TDL from TxBM mice) possessed  the receptor. The majority of lymphocytes 
whatever their size did so, but cells morphologically classifiable  as plasma cells 
or plasma blasts were never labeled (Fig. 2). 
The failure of plasmacytoid cells to bind antibody implied that the receptor 
for antibody is lost during differentiation of B cells into antibody-forming cells. 
Support for these observations was obtained from studies of various plasma cell 
tumors grown either in vivo or in vitro (Table VII). All of those tested lacked 
the  receptor  with  the  exception  of  HPC-6,  a  mutant  line  possessing  the 
morphological characteristics of a lymphoma rather than a plasma cell tumor. 
Binding of antibodv to this tumor has been independently demonstrated by 
a  rosette  technique2  The  absence  of  the  receptor  from  other  light  chain- 
secreting  plasma  cells  raises  the  interesting  possibility  that  development  of 
various tumors like HPC-6, which differ from their parent lines  in a deficiency 
of immunoglobulin synthesis or secretion, may represent a true dedifferentiation 
from plasma cells to B cells. Further studies will require the use of other B cell- 
plasma cell discriminatory markers. 
The possible  presence of the receptor on precursors of B cells was examined 
in  a  different  manner.  Suspensions  of bone  marrow  and  spleen  were  passed 
through a column designed to deplete lymphocyte populations of cells binding 
antibody. When the cells emerging in the effluent were tested for stem cell activ- 
ity in a colony-forming assay, significant enrichment was observed (Table VI). 
Thus  most  precursor  cells  have  not  yet  acquired  the  receptor  for  antibody. 
Taken together, the studies on differentiation make this a marker for mature B 
cells. It is not present on stem cells and is lost when B cells commence secreting 
immunoglobulin. The recent demonstration that an appreciable population of 
mobilizable  B  cells  are  long-lived  and  can  to  some  extent  recirculate, 9 
emphasizes the potential importance of a receptor of this kind in regulation of 
the immune response. 
SUMMARY 
Binding of antibody to the surface of B lymphocytes was shown to involve 
the  Fc piece  of the  immunoglobulin molecule. This  property was  not shared 
equally by all immunoglobulin classes  as revealed by direct binding and inhibi- 
8 Cline, M. J., J. Sprent, N. L. Warner, and A. W. Harris. 1971. Receptors for immuno- 
globulin on B lymphocytes  and cells of a cultured plasma cell tumor. Submitted for publication. 
9 St)rent, j., and A. Basten. Manuscript in preparation. A.  BASTEN,  N.  L.  WARNER,  AND  T.  MANDEL  641 
tion studies. Total IgG globulin was found to label cells more heavily than IgM, 
and IgGl-containing fractions more heavily than IgG2 fractions lacking IgG1. 
The ability of various purified myeloma proteins to inhibit attachment of anti- 
body to B  cells was examined. Pretreatment  of B  cells with excess IgG2a, IgA, 
or light chain proteins failed to inhibit,  whereas IgG1 proteins  and to a  lesser 
extent Ig2b and IgM proteins at the same concentrations did so. At lower pro- 
tein concentrations,  IgG1 myeloma protein  alone retained  the capacity to in- 
hibit  binding.  The  conclusion  was  reached  that  the  receptor  on  B  cells  for 
antibody has a marked predilection for the IgG1 class. Although IgM and IgG2b 
antibody may bind, they do so with lower avidity and probably in insignificant 
amounts  if IgG1 antibody is present in excess. 
No evidence was found to implicate complement in the binding process. For 
example,  heat-inactivated  sera at high dilution retained  the  ability to label  B 
cells, while the use of purified low molecular weight anticomplementary factor, 
a  potent inhibitor of C'3, did not interfere with the formation of the bond be- 
tween antibody and cell surface. 
The failure  of anti-mouse immunoglobulin F(ab)t~ fragments to prevent  ac- 
cess  of  antibody  to  B  cells  implied  that  the  antibody-binding  receptor  and 
antigen-binding  (immnnoglobulin)  receptor  are discrete  entities  on the  B  cell 
membrane. Despite this, a marked similarity between their surface distribution 
was observed on electron microscopy. 
The antibody-binding receptor was shown to be a marker for mature B  cells. 
It did not appear to be present on hematopoietic precursor stem cells and was 
lost during differentiation to antibody-forming cells. 
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